Clinical Trials on 罕见肿瘤 in Australia
总计6741个结果
-
Ludwig Institute for Cancer ResearchInstitute of Cancer Research, United Kingdom完全的
-
Antengene Biologics Limited招聘中
-
Ontario Clinical Oncology Group (OCOG)Pfizer完全的
-
Queensland Institute of Medical ResearchNational Health and Medical Research Council, Australia; Australian Department of Industry,... 和其他合作者完全的
-
Athenex, Inc.PharmaEssentia; Zenith Technology Corporation Limited完全的
-
Antengene Therapeutics LimitedMerck Sharp & Dohme LLC招聘中
-
Children's Oncology GroupNational Cancer Institute (NCI)完全的
-
University Medicine GreifswaldChildren's Cancer Research Institute, Austria主动,不招人
-
Epizyme, Inc.完全的滑膜肉瘤 | 上皮样肉瘤 | 肾髓质癌 | 恶性横纹肌样瘤 (MRT) | 肾脏横纹肌样瘤 (RTK) | 非典型畸胎样横纹肌样瘤 (ATRT) | 具有横纹肌样特征的选定肿瘤 | INI1 阴性肿瘤 | 卵巢恶性横纹肌样瘤 | 低分化脊索瘤(或其他经申办者批准的脊索瘤) | 任何具有 EZH2 GOF 突变的实体瘤法国, 美国, 澳大利亚, 台湾, 比利时, 英国, 加拿大, 德国, 意大利
-
University Hospital, ToursEuropean Academy of Dermatology and Venerology尚未招聘
-
The AlfredMerck Sharp & Dohme LLC完全的
-
Barwon HealthAustralasian Gastro-Intestinal Trials Group; Deakin University; Specialised Therapeutics Australia未知
-
Ludwig Institute for Cancer ResearchCancer Research Institute, NY, USA终止
-
Melanoma and Skin Cancer Trials LimitedMelanoma Institute Australia; Cancer Council New South Wales主动,不招人
-
Medical University of Graz完全的
-
Immunocore Ltd招聘中
-
GlaxoSmithKline完全的
-
CelgeneICON Clinical Research完全的